 Connection
Neel Butala to Transcatheter Aortic Valve Replacement
This is a "connection" page, showing publications Neel Butala has written about Transcatheter Aortic Valve Replacement.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
8.269 |
|
|
|
-
Joshi VA, Bucholz EM, Roll M, Rahman N, Kolte D, Davila C, Yeh RW, Cohen DJ, Waldo SW, Butala NM. Sex Differences in Stroke Frequency and Severity Following Transcatheter Aortic Valve Replacement. J Am Heart Assoc. 2025 Aug 05; 14(15):e041943.
Score: 0.764
-
Butala NM, Lalani C, Tale A, Song Y, Kolte D, Baron S, Strom J, Cohen DJ, Yeh RW. Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial. Circ Cardiovasc Interv. 2025 Jan; 18(1):e014592.
Score: 0.739
-
Butala NM, Kapadia SR, Yeh RW, Cohen DJ. Use of Discharge Disposition to Determine Stroke Severity After TAVR. Circ Cardiovasc Interv. 2024 Sep; 17(9):e013698.
Score: 0.707
-
Butala NM, Kapadia SR, Secemsky EA, Gallup D, Kosinski AS, Vemulapalli S, Messenger JC, Yeh RW, Cohen DJ. Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry. Circ Cardiovasc Interv. 2024 Sep; 17(9):e013697.
Score: 0.707
-
Butala NM, Wood DA, Li H, Chinnakondepalli K, Lauck SB, Sathananthan J, Cairns JA, Magnuson EA, Barker M, Webb JG, Welsh R, Cheung A, Ye J, Velianou JL, Wijeysundera HC, Asgar A, Kodali S, Thourani VH, Cohen DJ. Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAVR Economic Study. Circ Cardiovasc Interv. 2022 10; 15(10):e012168.
Score: 0.631
-
Butala NM, Oseran AS, Yeh RW. Innovation's Disjointed Path From Approval to Payment-The Case of Embolic Protection Devices for Transcatheter Aortic Valve Replacement. JAMA Cardiol. 2022 09 01; 7(9):953-954.
Score: 0.626
-
Butala NM, Secemsky E, Kazi DS, Song Y, Strom JB, Faridi KF, Brennan JM, Elmariah S, Shen C, Yeh RW. Applicability of Transcatheter Aortic Valve Replacement Trials to Real-World Clinical Practice: Findings From EXTEND-CoreValve. JACC Cardiovasc Interv. 2021 10 11; 14(19):2112-2123.
Score: 0.588
-
Butala NM, Song Y, Shen C, Cohen DJ, Yeh RW. Effect of intensive versus limited monitoring on clinical trial conduct and outcomes: A randomized trial. Am Heart J. 2022 01; 243:77-86.
Score: 0.585
-
Butala NM, Makkar R, Secemsky EA, Gallup D, Marquis-Gravel G, Kosinski AS, Vemulapalli S, Valle JA, Bradley SM, Chakravarty T, Yeh RW, Cohen DJ. Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results From the Transcatheter Valve Therapy Registry. Circulation. 2021 06 08; 143(23):2229-2240.
Score: 0.563
-
Butala NM, Strom JB, Faridi KF, Kazi DS, Zhao Y, Brennan JM, Popma JJ, Shen C, Yeh RW. Validation of Administrative Claims to Ascertain Outcomes in Pivotal Trials of Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2020 08 10; 13(15):1777-1785.
Score: 0.540
-
Butala NM, Chung M, Secemsky EA, Manandhar P, Marquis-Gravel G, Kosinski AS, Vemulapalli S, Yeh RW, Cohen DJ. Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes. JACC Cardiovasc Interv. 2020 06 08; 13(11):1277-1287.
Score: 0.536
-
Butala NM, Bucholz EM, Kolte D, Elmariah S. Association of Hospital Inpatient Percutaneous Coronary Intervention Volume With Clinical Outcomes After Transcatheter Aortic Valve Replacement and Transcatheter Mitral Valve Repair. JAMA Cardiol. 2020 04 01; 5(4):464-468.
Score: 0.529
-
Lalani C, Sharma RK, Sevilla-Cazes J, Kennedy K, Butala NM, Secemsky EA, Pinto D, Poulin MF, Laham R, Kolte D, Cohen DJ, Yeh RW. Outcomes of Percutaneous Coronary Interventions Following Transcatheter Aortic Valve Replacement: Insights From the CathPCI Registry. Am J Cardiol. 2025 Sep 15; 251:18-24.
Score: 0.189
-
Chung M, Butala NM, Faridi KF, Almarzooq ZI, Liu D, Xu J, Song Y, Baron SJ, Shen C, Kazi DS, Yeh RW. Days at home after transcatheter or surgical aortic valve replacement in high-risk patients. Am Heart J. 2023 01; 255:125-136.
Score: 0.158
-
Kolte D, Khera S, Nazir S, Butala NM, Bhatt DL, Elmariah S. Trends in Cerebral Embolic Protection Device Use and Association With Stroke Following Transcatheter Aortic Valve Implantation. Am J Cardiol. 2021 08 01; 152:106-112.
Score: 0.144
-
Strom JB, Faridi KF, Butala NM, Zhao Y, Tamez H, Valsdottir LR, Brennan JM, Shen C, Popma JJ, Kazi DS, Yeh RW. Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings From the EXTEND Study. Circulation. 2020 07 21; 142(3):203-213.
Score: 0.134
-
Strom JB, Zhao Y, Faridi KF, Tamez H, Butala NM, Valsdottir LR, Curtis J, Brennan JM, Shen C, Boulware M, Popma JJ, Yeh RW. Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND Study. Circ Cardiovasc Interv. 2019 11; 12(11):e008231.
Score: 0.129
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|